Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 18, 2024, Enfusion, Inc. (the “Company”) announced the appointment of Valeria Gutowski to the position of Chief Accounting Officer of the Company, effective January 15, 2024, upon which she became the Company’s principal accounting officer.
Since joining the Company in March of 2022, Ms. Gutowski, age 42, has been the Company’s Financial Controller. Prior to joining the Company, she was the Director of SEC, Technical Accounting and Strategic Initiatives at R. R. Donnelley & Sons Company, a provider of marketing, packaging, print, and supply chain solutions, from March of 2020 to March of 2022 and Senior Managing of Technical Accounting at Navistar Inc., a manufacturer of commercial vehicles and equipment, from June of 2018 to March of 2020. Prior to that, she spent 13 years with Ernst & Young LLP, holding positions of increasing responsibility primarily within the firm’s audit practice. She holds a Bachelor of Science in Finance from Brigham Young University, and a Master of Science in Accounting from the University of Notre Dame, and is a Certified Public Accountant.
In connection with her appointment as Chief Accounting Officer, Ms. Gutowski entered into a new Scope of Employment Appendix, with a commencement date of January 15, 2024, which modified her existing Employment Agreement, which has an effective date of February 7, 2022 (as modified, the “Employment Agreement”). Pursuant to her Employment Agreement she will (a) receive an annual base salary of $310,000, (b) have an annual discretionary target bonus of up to 30% of her base salary, and (c) be eligible to participate in the Company’s long-term equity incentive plan for executives, pursuant to which she is eligible to be granted restricted stock units that have a grant value equal to 25% of her base salary.
Under the Employment Agreement, Ms. Gutowski will be subject to twelve-month post-termination non-compete and non-solicit covenants, a six-month post-termination client competition covenant, and a perpetual confidentiality covenant.
In connection with her appointment, the Company will enter into an indemnification agreement with Ms. Gutowski that is substantially the same as those entered into with other officers of the Company. There are no family relationships between Ms. Gutowski and any director or executive officer of the Company. In addition, Ms. Gutowski has no direct or indirect material interest in any transaction or proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Item 7.01 – Regulation FD Disclosure
On January 18, 2024, the Company issued a press release announcing the appointment described above.
The information in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 – Financial Statements and Exhibits
(d) The following exhibits are being filed herewith:
